Figure 2: A vaccine was prepared from allogeneic and syngeneic cells administered in a fractionated regimen together with BCG and IL-2.
A) Treatment schedule representing the cycle of the various immunotherapeutic injections. AC, allogenic cells, SC, syngeneic cells, AL, allogeneic lysate, SL, syngeneic lysate, Ly, is lysate only.
B) Average values of tumor growth as a function of time post-implantation for the different treatment groups.